A French, Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)
Observational
Observational Model: Cohort, Time Perspective: Prospective
Satisfaction
Satisfaction will be assessed using a 4-point Likert scale.
Satisfaction will be assessed approximately 1 hour after each BTPc episode treated with PecFent® from completion of titration through Day 7
No
Alain Serrie, MD
Principal Investigator
Head of Pain Federation - Palliative Medicine Lariboisiere Hospital, Paris France
France: Agence Nationale de Sécurité du Médicament et des produits de santé
CP057/11
NCT01693328
September 2012
Name | Location |
---|